China
Africa
Explore chapters and articles related to this topic
Psychotropic use in Australian aged care homes
Published in Bernadette McSherry, Yvette Maker, Restrictive Practices in Health Care and Disability Settings, 2020
In one-to-one interviews, all of the general practitioners interviewed said they were asked to prescribe these medications primarily by the staff. None of the general practitioners could recall being asked for these medications by relatives. They reported that they assumed that non-drug strategies had been trialled before being asked to prescribe. Half of the general practitioners interviewed said that by using low doses they minimised side effects and would justify use by stating they only used just a ‘small amount’. The interviewees suggested that comprehensive assessment of a resident’s symptoms as recommended by most professional guidelines occurred infrequently; review of psychotropic medications did not occur routinely, if at all. There was marked reluctance shown by staff to alter medications or doses due to the possibility that behavioural or psychological symptoms would worsen or reappear (Westbury 2011).
Work experience
Published in Viyaasan Mahalingasivam, Marc A Gladman, Manoj Ramachandran, Secrets of Success: Getting into Medical School, 2020
There are plenty of organizations that provide opportunities for voluntary work, particularly in developing countries. However, you should always verify their suitability independently. You should also make sure that you have travel insurance (see www.moneysupermarket.com/travelinsurance/?source=MS) and visit your GP to ensure that you have taken all the necessary precautions for your own health. It is a good idea to travel with friends on whom you can rely, and you should plan as many details of your placement in advance as possible, especially your budget! There is a vast amount of information available online about almost every destination in the world, and there are also many relevant books worth having a look at.
Twenty years of cures for the French health care system
Published in Elias Mossialos, Julian Le Grand, Health Care and Cost Containment in the European Union, 2019
Pierre-Jean Lancry, Simone Sandier
The relationship between private doctors, their patients, and the Assurance-maladie, is regulated by contracts (Conventions), the last of which was signed by two doctors' trade unions in 1993, later joined by a third in 1995. Patients may consult a specialist without a referral by their general practitioner. Private doctors can prescribe any treatments or diagnostic tests for their patients. They are paid on a fee-for-service basis, according to a negotiated fee schedule. About 30 per cent of doctors ('Secteur 2') can exceed these fees (see section 9.3).
Managing children with daytime urinary incontinence: a survey of Dutch general practitioners
Published in European Journal of General Practice, 2023
Antal P. Oldenhof, J. Marleen Linde, Ilse Hofmeester, Martijn G. Steffens, Francis J. Kloosterman-Eijgenraam, Marco H. Blanker
The treatment of UI in the Netherlands is multidisciplinary. Parents first seek help from a general practitioner (GP) or youth healthcare practitioner. If these physicians cannot resolve the problem, they can refer the child to a paediatrician or (paediatric) urologist. Although the Dutch associations of Urology and Paediatrics have collaborated to create guidance for assessing and treating daytime UI [8], no specific guideline exists for GPs. Studies in New Zealand and Australia showed that confidence in managing daytime UI seems to vary in primary care [9,10]. No comparable studies are available in the Netherlands and it is unclear how Dutch GPs approach daytime UI in children, how confident they are with this care, and on what basis they refer to secondary care. We aimed to identify these topics.
Current status and prospect for future advancements of long-acting antibody formulations
Published in Expert Opinion on Drug Delivery, 2023
Puneet Tyagi, Garrett Harper, Patrick McGeehan, Shawn P Davis
The authors have highlighted multiple technical approaches to modifying the pharmacokinetics of mAbs. These approaches include engineering the protein directly to slow its clearance, encapsulation of the protein in matrices that control its release, and formulation and device technologies to support larger doses. All of these approaches are modality specific and each presents unique advantages and challenges, any of which may allow one to reduce the dosing frequency of mAbs by weeks or even months. With that in mind, the authors wish to challenge the industry to consider what could be achieved with a concerted effort to push the boundaries of these technologies. What would be an ideal dosing frequency for our patients if our understanding of the safety and efficacy were in hand? Dosing every six months is already a reality for some products (denosumab, Prolia®). Could an annual visit to your general practitioner serve as both a diagnostic visit as well as dosing for your chronic disease?
Comparison of parent reported physician diagnosed asthma and general practitioner registration
Published in Journal of Asthma, 2023
Marianne Eijkemans, Monique Mommers, Carel Thijs
In the Netherlands the general practitioner (GP) is the central person in the patient’s healthcare, and acts as a gatekeeper for the patient’s health and that of their family. In general, asthma is diagnosed by the general practitioner or pediatrician by clinical observation of recurrent episodes of dyspnea and wheeze, preferably supported by a spirometry with reversible bronchoconstriction. In general, mild asthma with only on demand bronchodilators or stable with normal dosage of inhaled corticosteroids, is treated by the general practitioner. Moderate or severe asthma is treated by the pediatrician. The pediatrician will inform the general practitioner of the diagnosis and treatment with regular correspondence, as the general practitioner is the gatekeeper of the patient’s health in general (10).